Randomized, parallel group, controlled trial of EPA for the prevention of atrial fibrillation following coronary artery bypass surgery

Randomized, parallel group, controlled trial of EPA for the prevention of atrial fibrillation following coronary artery bypass surgery - Preventive effect of EPA against atrial fibrillation following coronary artery bypass surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004209

Enrollment

150

Registered

2010-09-15

Start date

2010-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation Coronary artery bypass surgery

Interventions

usual care plus EPA usual care

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Elective coronary artery bypass surgery Hyperlipidemia Older than 20 years and younger than 80 years of age

Exclusion criteria

Exclusion criteria: Prior history of atrial fibrillation Prior history of valvular surgery Prior history of EPA side effect

Design outcomes

Primary

Measure	Time frame
Incidence of atrial fibrillation during the postoperative hospitalization.	—

Secondary

Measure	Time frame
Correlation between occurrence of atrial fibrillation and serum EPA/AA. Adverse events of EPA.	—

Countries

Japan

Contacts

Public ContactKatsuhiko Imai

Hiroshima university hospital Department of cardiovascular surgery

082-257-5216

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026